Plasma hsa-mir-19b is a potential LevoDopa therapy marker.
Chis AR, Moatar AI, Dijmarescu C, Rosca C, Vorovenci RJ, Krabbendam I, Dolga A, Bejinar C, Marian C, Sirbu IO, Simu M.
Chis AR, et al.
J Cell Mol Med. 2021 Sep;25(18):8715-8724. doi: 10.1111/jcmm.16827. Epub 2021 Jul 30.
J Cell Mol Med. 2021.
PMID: 34328686
Free PMC article.